AMEX : EVX

VanEck Environmental Services ETF

$40.92 USD

$0.45 (1.11%)

Volume
2.2K
Average Volume
7.73K
Market Capitalization
$102.4M
P/E Ratio
Dividend Yield
%
Price Target
Year High
$42.44
Year Low
$36.44
Day High
Day Low
Payout Ratio
Current Ratio
Company Overview

AMEX

Asset Management

Financial Services

EVX

N/A

US

USD

1-800-826-2333

92189F304

0001137360

Liquidity Metrics

Sales & Valuation

-$

Profitability

-$

%

%

%

%

P/E Metrics

Analyst Price Target & Rating

N/A

0/5

0 Analysts

%

Financial Health Scores

No financial score data available.

Key Metrics (TTM)

No key metrics data available.

Company Executives

No executive data available.

Poll Results

No votes yet today — be the first to share your view!

About VanEck Environmental Services ETF (AMEX:EVX) Stock

The VanEck Environmental Services ETF (EVX) aims to closely mirror the price and yield performance of the MarketVector Global Environmental Services Index (MVEVX), before accounting for its own fees and expenses. This index tracks companies primarily involved in various environmental services, including environmental consulting and modeling, wastewater and drainage management, general waste disposal, environmental remediation and protection, non-industrial air filtration, and technologies for carbon capture, waste-to-energy, and biofuel production, though it excludes certain recycling activities. ...

Evaxion to present three-year clinical efficacy data for personalized cancer vaccine EVX-01 at the ESMO Congress 2026

2026-07-17 07:15:00

COPENHAGEN, Denmark, July 17, 2026 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company developing novel vaccines with its pioneering AI-Immunology™ platform, will present three-year clinical efficacy data from its phase 2 trial with personalized cancer vaccine candidate EVX-01 at the European Society for Medical Oncology (ESMO) Congress 2026 to be held in Madrid, Spain, from October 23-27, 2026.

Evaxion presents new preclinical data for cytomegalovirus vaccine program EVX-V1

2026-07-12 09:30:00

COPENHAGEN, Denmark, July 12, 2026 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company developing novel vaccines with its pioneering AI-Immunology™ platform, presents new data further supporting the multi-component concept of its cytomegalovirus (CMV) vaccine program EVX-V1.

Evaxion to present new preclinical data for cytomegalovirus vaccine candidate EVX-V1 at the International Herpesvirus Workshop

2026-07-01 08:00:00

COPENHAGEN, Denmark, July 1, 2026 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company developing novel vaccines with its pioneering AI-Immunology™ platform, will present new preclinical data for vaccine candidate EVX-V1 in a poster session at the International Herpesvirus Workshop (IHW) 2026 taking place in Montreal, Canada, July 11-15, 2026.

Evaxion presents new preclinical data for EVX-04, an off-the-shelf therapeutic vaccine for acute myeloid leukemia

2026-06-11 02:00:00

COPENHAGEN, Denmark, June 11, 2026 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company developing novel vaccines with its pioneering AI-Immunology™ platform, announces new preclinical data for EVX-04, an off-the-shelf therapeutic vaccine for acute myeloid leukemia (AML). Developed with AI-Immunology™, EVX-04 targets multiple non-conventional endogenous retrovirus (ERV) tumor antigens from the dark genome.

Evaxion to present new data for EVX-04, an off-the-shelf therapeutic vaccine for acute myeloid leukemia, at the EHA 2026 Congress

2026-05-12 09:30:00

COPENHAGEN, Denmark, May 12, 2026 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company developing novel vaccines with its pioneering AI-Immunology™ platform, will announce the functional characterization of EVX-04, an off-the-shelf therapeutic acute myeloid leukemia (AML) vaccine, in a poster presentation at the European Hematology Association (EHA) 2026 Congress taking place in Stockholm, Sweden, June 11-14, 2026.

Frequently Asked Questions

What is the current VanEck Environmental Services ETF (EVX) stock price?

VanEck Environmental Services ETF(AMEX:EVX) stock price is $40.92 in the last trading session. During the trading session, EVX stock reached the peak price of $42.44 while $36.44 was the lowest point it dropped to. The percentage change in EVX stock occurred in the recent session was 1.11% while the dollar amount for the price change in EVX stock was $0.45.

EVX's industry and sector of operation?

The AMEX listed EVX is part of Asset Management industry that operates in the broader Financial Services sector.

Who are the executives of EVX?

|
|
|
|
|

How many employees does EVX have?

Number of EVX employees currently stands at None. EVX operates from 666 Third Avenue, 9th Floor, New York, NY 10017, US.

Link for EVX official website?

How do I contact EVX?

EVX could be contacted at phone #1-800-826-2333 and can also be accessed through its website. EVX operates from 666 Third Avenue, 9th Floor, New York, NY 10017, US.

How many shares of EVX are traded daily?

The average number of EVX shares traded daily for last 3 months was 7.73K.

What is the market cap of EVX currently?

The market value of EVX currently stands at $102.4M with its latest stock price at $40.92